126 related articles for article (PubMed ID: 11052786)
1. 7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1, 5-a]quinoxaline-2- carboxylates as novel highly selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2000 Oct; 43(21):3824-6. PubMed ID: 11052786
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173.
Catarzi D; Colotta V; Varano F; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2001 Sep; 44(19):3157-65. PubMed ID: 11543685
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 9-heteroaryl substituted 7-chloro-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates (TQX) as (R,S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptor antagonists.
Catarzi D; Colotta V; Varano F; Filacchioni G; Gratteri P; Sgrignani J; Galli A; Costagli C
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1085-91. PubMed ID: 18670107
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists.
Varano F; Catarzi D; Colotta V; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2002 Feb; 45(5):1035-44. PubMed ID: 11855983
[TBL] [Abstract][Full Text] [Related]
7. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel quinoxaline-2,3-dione AMPA/GlyN receptor antagonists: amino acid derivatives.
Nikam SS; Cordon JJ; Ortwine DF; Heimbach TH; Blackburn AC; Vartanian MG; Nelson CB; Schwarz RD; Boxer PA; Rafferty MF
J Med Chem; 1999 Jun; 42(12):2266-71. PubMed ID: 10377233
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.
Catarzi D; Lenzi O; Colotta V; Varano F; Poli D; Filacchioni G; Lingenhöhl K; Ofner S
Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):908-11. PubMed ID: 20606335
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists.
Auberson YP; Bischoff S; Moretti R; Schmutz M; Veenstra SJ
Bioorg Med Chem Lett; 1998 Jan; 8(1):65-70. PubMed ID: 9871630
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
14. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
15. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo.
Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
Eur J Med Chem; 2001 Feb; 36(2):203-9. PubMed ID: 11311751
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists.
Auberson YP; Acklin P; Allgeier H; Biollaz M; Bischoff S; Ofner S; Veenstra SJ
Bioorg Med Chem Lett; 1998 Jan; 8(1):71-4. PubMed ID: 9871631
[TBL] [Abstract][Full Text] [Related]
18. 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists.
Mignani S; Bohme GA; Boireau A; Cheve M; Damour D; Debono MW; Genevois-Borella A; Imperato A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Stutzmann JM
Bioorg Med Chem Lett; 2000 Mar; 10(6):591-6. PubMed ID: 10741560
[TBL] [Abstract][Full Text] [Related]
19. 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
Catarzi D; Colotta V; Varano F; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Montopoli C; Moro S
J Med Chem; 2005 Dec; 48(25):7932-45. PubMed ID: 16335918
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.
Takano Y; Shiga F; Asano J; Ando N; Uchiki H; Fukuchi K; Anraku T
Bioorg Med Chem; 2005 Oct; 13(20):5841-63. PubMed ID: 15993606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
